Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANUH PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ANUH PHARMA   MYLAN
EQUITY SHARE DATA
    ANUH PHARMA
Mar-23
MYLAN
Dec-18
ANUH PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1103,972-   
Low Rs772,186-   
Sales per share (Unadj.) Rs105.31,827.6-  
Earnings per share (Unadj.) Rs7.249.6-  
Cash flow per share (Unadj.) Rs9.2391.8-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs48.11,977.1-  
Shares outstanding (eoy) m50.11514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.7 52.7%   
Avg P/E ratio x12.962.0 20.9%  
P/CF ratio (eoy) x10.27.9 129.9%  
Price / Book Value ratio x1.91.6 124.7%  
Dividend payout %27.70-   
Avg Mkt Cap Rs m4,6831,584,113 0.3%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1720-   
Avg. sales/employee Rs Th026,865.3-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.5-  
INCOME DATA
Net Sales Rs m5,275940,285 0.6%  
Other income Rs m610-   
Total revenues Rs m5,336940,285 0.6%   
Gross profit Rs m518243,311 0.2%  
Depreciation Rs m97176,058 0.1%   
Interest Rs m745,224 0.0%   
Profit before tax Rs m47522,028 2.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m113-3,504 -3.2%   
Profit after tax Rs m36225,533 1.4%  
Gross profit margin %9.825.9 38.0%  
Effective tax rate %23.8-15.9 -149.5%   
Net profit margin %6.92.7 252.6%  
BALANCE SHEET DATA
Current assets Rs m3,076525,055 0.6%   
Current liabilities Rs m1,613382,823 0.4%   
Net working cap to sales %27.715.1 183.3%  
Current ratio x1.91.4 139.0%  
Inventory Days Days6684 78.6%  
Debtors Days Days1,18593 1,269.7%  
Net fixed assets Rs m966182,400 0.5%   
Share capital Rs m251501 50.0%   
"Free" reserves Rs m2,1620-   
Net worth Rs m2,4121,017,217 0.2%   
Long term debt Rs m01,097,904 0.0%   
Total assets Rs m4,0422,728,571 0.1%  
Interest coverage x64.61.5 4,346.4%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.30.3 378.7%   
Return on assets %9.12.6 352.3%  
Return on equity %15.02.5 597.5%  
Return on capital %20.03.2 628.6%  
Exports to sales %52.50-   
Imports to sales %53.20-   
Net fx Rs m-380-   
CASH FLOW
From Operations Rs m539195,391 0.3%  
From Investments Rs m-435-100,996 0.4%  
From Financial Activity Rs m-123-91,025 0.1%  
Net Cashflow Rs m-191,619 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.44 Rs / USD

Compare ANUH PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ANUH PHARMA With: LAURUS LABS   FDC  BIOFIL CHEMICALS  IPCA LABS  ORCHID PHARMA  



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.